Pharmafile Logo
Pharmafocus logo
Advanced Search
Lilly image

Lilly and Boehringer diabetes biosimilar sees EU approval

September 11, 2014
Sales and Marketing Boehringer, EU, European Commission, Lantus, Sanofi, diabetes, lilly

Lilly and Boehringer Ingelheim’s insulin glargine product has been shown the green light by the European Commission (EC). The copycat …

News

FDA approves new indication for Xtandi

September 11, 2014
Sales and Marketing Astellas, FDA, Medivation, Xtandi, Zytiga, prostate

The FDA has approved Astellas Pharma and Medivation’s prostate cancer drug Xtandi (enzalutamide) for use in patients who have not …

News
fda image

Fourth diet pill makes it to US market

September 11, 2014
Manufacturing and Production, Sales and Marketing Contrave, FDA, Orexigen Therapeutics, diet, obesity

Orexigen Therapeutics has gained FDA approval for its new obesity treatment Contrave to help overweight patients reduce their food intake. …

News
peter_impey_10ten

90TEN Healthcare appoints comms director

September 11, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 90TEN, Lottie Tupholme, Peter Impey, Steve Ramsey

London comms agency 90TEN Healthcare has hired Peter Impey as its director of international communications, and added two heads to …

Appointment

NICE seeks more trial data from pharma

September 10, 2014
Medical Communications, Research and Development, Sales and Marketing David Haslam, NICE, Tamiflu, alltrials, transparency

NICE is calling on pharma to release more data so it can better assess the costs of new medicines.The watchdog …

News
ERS event image

InterMune’s IPF drug shines at ERS Congress

September 10, 2014
Research and Development, Sales and Marketing Boehringer, ERS, Esbriet, IPF, InterMune, idiopathic pulmonary fibrosis, munich, pirfenidone

InterMune has posted positive data for its lung-scarring drug at this year’s European Respiratory Society Annual Congress 2014 (ERS). Pharmafile …

News
Apple image

Apple launches health-centred smartwatch

September 10, 2014
Medical Communications, Research and Development, Sales and Marketing Android, Apple, Jobs, Samsung, apple watch, google, health kit

Apple has finally unveiled its long-rumoured ‘smartwatch’ to the world along with new iPhones and a payment system. At the …

News
Evotec image

Trial misconduct halts Evotec/Hyperion drug

September 10, 2014
Research and Development, Sales and Marketing DiaPep277, Evotec, amdromeda, diabetes, hyperion

Development of Evotec and Hyperion Therapeutic’s diabetes drug DiaPep277 has been terminated following ‘serious misconduct’ in one of its trials. …

News
edward_mullin_liberation

Liberation appoints account co-ordinator

September 10, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Edward Mullin, Liberation, communications

UK-based healthcare comms agency Liberation has hired a new starter to its team with the appointment of Edward Mullin as …

Appointment
FTC building

Federal Trade Commission sues AbbVie and Teva

September 9, 2014
Manufacturing and Production, Sales and Marketing AbbVie, FTC, Teva, androgel, federal trade commission

Authorities in the US claim that AbbVie and Teva filed ‘sham’ lawsuits in a complicated pay-to-delay case for generic forms …

News
Parkinson's image

‘Pocket doctor’ on the horizon for Parkinson’s

September 9, 2014
Medical Communications, Sales and Marketing Nonlinearity and Complexity Research Group, Parkinson's, aston, dr little, pocket doctor

Smartphones will soon be able to perform the functions of a ‘pocket doctor’ and map Parkinson’s disease and other degenerative …

News
Celgene image

Celgene rebuffed by NICE over cancer drug

September 9, 2014
Sales and Marketing Abraxane, Cancer, Celgene, Gemzar, NICE, gemcitabine, nab-paclitaxel

In new draft guidance NICE says that Celgene’s Abraxane (nab-paclitaxel) taken with Lilly’s Gemzar (gemcitabine) should not be funded by …

News

New chief executive and chairman for Evaluate

September 9, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing alex karle, evaluate

Life science market intelligence firm Evaluate has appointed Alex Karle to the role of chief executive, replacing the firm’s founder Dr …

Appointment
screen_shot_2014-09-08_at_17

New chief executive for ReNeuron

September 8, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Olav Hellebø, ReNeuron, clavis

UK-based stem cell therapy firm ReNeuron has appointed Olav Hellebø to be its new chief executive. Since starting his pharma …

Appointment
NHS image

NHS cancer services not holding up, says report

September 8, 2014
Research and Development, Sales and Marketing CRUK, Cancer, NHS, UK, government, oncology

NHS cancer services are in urgent need of investment and review, according to a new report commissioned by Cancer Research …

News
servier image

Servier slammed over UK trial transparency failure

September 8, 2014
Medical Communications, Research and Development, Sales and Marketing ABPI, PMCPA, Servier, code, conduct, transparancy, trials

Servier has been found guilty of the most serious breach of the UK’s pharma code of conduct after failing to …

News
merck image

BMS sues Merck over new melanoma drug

September 8, 2014
Research and Development, Sales and Marketing BMS, FDA, Merck, PD-1 inhibitors, Yervoy, keytruda

Things are getting ugly between Bristol-Myers Squibb and Merck as the former company began legal proceedings against the latter over …

News

MHRA leads social media drug safety initiative

September 8, 2014
Medical Communications, Sales and Marketing EFPIA, EU, MHRA, social media, web-radr

The MHRA has announced that it is to lead European medicines regulators, academics and pharma in a three-year project to …

News
BMS image

Bristol-Myers Squibb: following the string of pearls

September 8, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, BMS, GSK, Johanna Mercier, Pfizer, UCB, Yervoy, acquisitions

Bristol-Myers Squibb (BMS) is something of an enigma in the pharma industry. Whilst many of its big pharma peers are …

Feature
david_caumartin

Theraclion hires chief executive and VP

September 8, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Anja Kleber, David Caumartin, Theraclion

French medical device firm Theraclion has appointed David Caumartin as its chief executive and Anja Kleber as vice president of …

Appointment
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026